Literature DB >> 12536226

Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections.

Y Horikoshi1, A Sasaki, N Taguchi, M Maeda, H Tsukagoshi, K Sato, H Yamaguchi.   

Abstract

In neuropathological studies it is important to detect both resting and reactive microglia in paraffin sections. We examined the usefulness of human (h) GLUT5, a glucose transporter, as a microglial marker. We produced an hGLUT5 antibody against its C-terminal sequence and stained human brain tissue sections. The hGLUT5 antibody consistently stained microglia in cryostat sections. In paraffin sections fixed with formalin, paraformaldehyde or ethanol, both resting and reactive microglia were stained; the latter were stained more intensely than the former. The hGLUT5 and glial fibrillary acidic protein labeling did not overlap each other in double immunofluorescence analyses. Oligodendrocytes, perivascular cells, choroid plexus epithelium and ependymal cell were negative for hGLUT5. Even after 1-month fixation in formalin, the hGLUT5 antibody stained microglia well. Microwave pretreatment enhanced the immunoreactivity of hGLUT5. As compared with other microglial markers, KP-1, KiM1p, CR3.43 and RCA-1, the hGLUT5 antibody could be considered good morphological marker. hGLUT5 immunolabeling clearly showed the detailed microglial processes, whereas immunolabeling with Ki-M1P and KP-1 showed cytoplasmic granules, and it was difficult to trace the microglial processes. The hGLUT5 antibody stained both resting and reactive microglia, whereas CR3.43 stained only reactive microglia, and RCA-1 labeled microvessels more intensely than microglia. Thus, hGLUT5 is a marker that is suitable for routine histopathological staining procedures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536226     DOI: 10.1007/s00401-002-0627-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 3.  Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain".

Authors:  Edith V Sullivan; Natalie M Zahr
Journal:  Exp Neurol       Date:  2008-07-14       Impact factor: 5.330

Review 4.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

5.  Specific regions of the brain are capable of fructose metabolism.

Authors:  Sarah A Oppelt; Wanming Zhang; Dean R Tolan
Journal:  Brain Res       Date:  2016-12-27       Impact factor: 3.252

6.  Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy.

Authors:  Juan T Borda; Xavier Alvarez; Mahesh Mohan; Marion S Ratterree; Kathrine Phillippi-Falkenstein; Andrew A Lackner; Bruce A Bunnell
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

7.  Increased MCP-1 and microglia in various regions of the human alcoholic brain.

Authors:  Jun He; Fulton T Crews
Journal:  Exp Neurol       Date:  2007-12-03       Impact factor: 5.330

8.  Glial-neuronal interactions underlying fructose utilization in rat hippocampal slices.

Authors:  Y Izumi; C F Zorumski
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

9.  Direct anti-inflammatory effects of angiotensin-(1-7) on microglia.

Authors:  Meng Liu; Peng Shi; Colin Sumners
Journal:  J Neurochem       Date:  2015-10-30       Impact factor: 5.372

10.  Effects of chronic low dose rotenone treatment on human microglial cells.

Authors:  Shamim B Shaikh; Louise Fb Nicholson
Journal:  Mol Neurodegener       Date:  2009-12-31       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.